导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.65% | 137/354 |
| 近一周 | -1.56% | 158/356 |
| 近一月 | -3.50% | 221/362 |
| 近一季 | -2.60% | 224/362 |
| 近半年 | 15.46% | 109/358 |
| 近一年 | 13.39% | 130/349 |
| 近两年 | 35.37% | 153/314 |
| 近三年 | 65.12% | 62/244 |
| 成立以来 | 441.26% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.36% 219/360 |
24.10% 70/366 |
- - |
- - |
| 2025 | 14.36% 240/358 |
-9.26% 304/340 |
15.92% 85/348 |
7.61% 201/354 |
1.04% 125/358 |
| 2024 | 23.07% 66/329 |
7.77% 80/280 |
7.36% 74/310 |
0.02% 248/318 |
6.35% 45/329 |
| 2023 | 54.43% 8/275 |
18.30% 26/205 |
20.56% 10/230 |
-3.58% 82/262 |
12.30% 53/276 |
| 2022 | -26.95% 128/201 |
-9.27% 80/153 |
-18.07% 131/164 |
0.30% 35/189 |
-2.03% 168/202 |
| 2021 | 22.98% 34/150 |
2.14% 131/312 |
9.14% 76/328 |
1.17% 43/358 |
9.04% 37/151 |
| 2020 | 35.23% 17/103 |
-10.39% 132/280 |
28.03% 57/295 |
8.77% 56/299 |
8.36% 145/305 |
| 2019 | 36.60% 11/88 |
13.24% 68/258 |
5.73% 27/268 |
3.62% 51/253 |
10.11% 76/266 |
| 2018 | 3.90% 6/79 |
- - |
- - |
- - |
-15.81% 177/241 |
| 2017 | 20.96% 27/69 |
- - |
- - |
- - |
- - |
| 2016 | 8.13% 22/59 |
- - |
- - |
- - |
- - |
| 2015 | 16.30% 3/49 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 大成纳斯达克100ETF联接(QDII)A VS. 建信富时100指数(QDII)人民币A(539003) |